
Join to View Full Profile
1120 NW 14th StreetMiami, FL 33136
Dr. Coffey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 2012 - 2015
University of ColoradoResidency, Internal Medicine, 2009 - 2012
University of Colorado School of Medicine Anschutz Medical CampusClass of 2009, MD
Tulane UniversityBS, Biology, 1999 - 2003
Certifications & Licensure
FL State Medical License 2021 - 2026
WA State Medical License 2012 - 2022
CO State Medical License 2009 - 2012
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Tocilizumab prophylaxis for patients with multiple myeloma treated with bispecific antibodies.Andrew Kowalski, Jill Lykon, Benjamin Diamond, David Coffey, Marcella Kaddoura
Blood Advances. 2025-10-14 - Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials.Andrew J Portuguese, Sherilyn A Tuazon, Margot J Pont, Gabriel O Cole, Blythe D Sather
Transplantation and Cellular Therapy. 2025-09-08 - 1 citationsOutcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort study.Shagun Singh, Supriya Peshin, Betsy C Wertheim, Ashley Larsen, Iloabueke Chineke
Haematologica. 2025-09-01
Journal Articles
- FAS ligand gene transfer for cancer therapyJaime F Modiano, Angela R Lamerato-Kozicki, CM Jubala, David G Coffey, Michelle Borakove, Jerome Schaack, and Donald Bellgrau, Cancer Therapy
Abstracts/Posters
- Efficacy and Safety of Fully Human Bcma CAR T Cells in Combination with a Gamma Secretase Inhibitor to Increase Bcma Surface Expression in Patients with Relapsed or Re...David G. Coffey, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Targeted Next Generation Sequencing of Circulating Tumor DNA in Multiple MyelomaCoffey DG, Orneals S, Towlerton AMH, Warren EH, Blood 2017 130:4337, American Society of Hematology Annual Meeting, 2017
- Simultaneous Detection Of Single Nucleotide Variants, mRNA Transcripts, And Protein Expression In Myeloma Bone Marrow AspiratesCoffey DG, Lombardo KA, Towlerton AMH, Farwell MA, Meredith G, Meredith R, Green DJ, Warren EH, Blood 2017 130:1758, American Society of Hematology Annual Meeting, 2017
- Join now to see all
Lectures
- High-Throughput Functional Drug Screening and Genomic Analysis to Guide Individualized Therapy for Relapsed/Refractory Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Reduced Antigen Presentation May Contribute to Immunomodulatory Drug Resistance in Multiple Myeloma61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
Press Mentions
Mission Bio and University of Miami Collaborate on Multiple Myeloma ResearchDecember 2nd, 2024
Mission Bio Announces Partnership to Advance Multiple Myeloma InsightsDecember 2nd, 2024
Mission Bio Partners with Top Researchers from University of Miami to Accelerate Early Relapse Detection & Treatment Selection of Multiple Myeloma PatientsDecember 2nd, 2024- Join now to see all
Grant Support
- Research Training Award for FellowsAmerican Society of Hematology2015–2016
Professional Memberships
- Member
- Society for Immunotherapy of CancerMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









